What is Patent Term Adjustment and Why Does It Matter?

by Perkins Coie

For patents granted on applications filed on or after June 8, 1995, the enforceable patent term begins on the day the patent issues and generally expires 20 years from the earliest effective filing date of the application.  Because the expiration date is calculated from the date of filing—rather than the date of issuance—delays in prosecuting the patent application reduce the enforceable term of the patent.  As a result, a patent applicant can maximize patent term by avoiding delays in prosecution.

But what happens when the U.S. Patent and Trademark Office (USPTO) delays prosecuting an application and thus potentially reduces the valuable patent term through no fault of the applicant?  To compensate for such patent office delays, 35 U.S.C. § 154 provides Patent Term Adjustment (PTA) that extends the term of a patent on a day-by-day basis. 

The A, B, Cs of PTA Calculations

Section 154 provides three different categories of PTA.  In particular, an applicant may receive A-Type (delayed response) PTA for: 1) each day after 14 months from the filing date of the application until the USPTO issues a first Office Action, and 2) each day after four months from the filing of certain actions by the applicant until the USPTO responds to such actions.  The applicant may receive B-Type (overall delay) PTA for each day after three years from the earliest effective filing date of the application until a patent is granted.  Likewise, the applicant may receive C-Type (other delay) PTA for each day of delay due to interferences, secrecy orders and successful appeals.  The total amount of PTA is calculated by adding the A-, B- and C-Type PTAs, and then subtracting any delay that is attributable to the applicant, e.g., each day beyond three months that it takes the applicant to respond to an Office Action.  The term of an issued patent is extended by the calculated total days of PTA.

Recent Case Law Regarding PTA

An interesting aspect of calculating PTA arises when an applicant files a first Request for Continued Examination (RCE) during prosecution.  Before November 1, 2012, the USPTO calculated PTA by stopping accrual of B-Type PTA after an applicant filed a first RCE.  On Nov. 1, 2012, the U.S. District Court for the Eastern District of Virginia decided Exelixis v. Kappos (Exelixis I) and held that accrual of B-Type PTA should be stopped only when the first RCE was filed within three years of the filing date of the patent application.  This meant that additional PTO should be added for the many applications where a first RCE was filed after the three-year mark.  Exelixis I was significant as it added several hundred days of PTA in some cases.

In January 2013, a subsequent decision by a different judge in the Eastern District of Virginia disagreed with the Exelixis I ruling, and in this subsequent ruling (Exelixis II) the court held that the USPTO’s previous method of cutting off B-Type PTA after the first RCE, no matter when it was filed, was correct.  Thus, there was a split in the court.

In January 2014, the Federal Circuit resolved this split in Novartis v. Lee (Novartis) in favor of Exelixis II.  The Federal Circuit held that any RCE, irrespective of when the RCE is filed, cuts off accrual of B-Type PTA.  However, the Federal Circuit also found that, contrary to the USPTO's then practice, B-Type PTA should resume accruing once a Notice of Allowance is mailed.  In June 2014, the USPTO is implementing new PTA calculation procedures to conform to Novartis.  The effect of the new procedures will be that "the time consumed by continued examination does not include the time after a notice of allowance, unless the Office actually resumes examination of the application after allowance."  (79 FR 34681, June 18, 2014)

Tips for Maximizing PTA

  • Appeal Before a First RCE

    Often during the prosecution of a patent application, an applicant will go through several rounds of Office Actions, possibly including filing multiple RCEs in response to Final Office Actions, before resorting to appealing a rejection.  In evaluating whether an appeal is an appropriate next step, applicants should consider the potential PTA benefits of appealing before filing a first RCE when the claims and evidence of record are in good condition for a successful appeal.  As discussed above, filing an RCE cuts off accrual of B-Type PTA for the remainder of prosecution until a Notice of Allowance is mailed.  By appealing before filing an RCE, when more than three years have elapsed since the filing of an application, an examiner's reopening of prosecution, either in response to an appeal brief or in response to a successful appeal, will resume accrual of B-Type PTA.  In many cases appealing before filing an RCE may result in months or years of extra PTA being added to the patent term. On the other hand, applicants are also wise to consider the competing concerns that may influence a decision to appeal before a first RCE.  Particularly with respect to patent applications in the biotechnology and pharmaceutical arts, care should be taken to avoid prematurely appealing a case, e.g., before resolving factual disputes over cited art.  The added expense of the appeals process, compared to the expense of continuing regular prosecution, may also weigh against a decision to appeal before a first RCE.
  • Fight Terminal Disclaimers

    During prosecution, the patent office may reject one or more claims in an application based on obviousness-type double patenting.  In most circumstances the applicant can overcome such a rejection by filing a terminal disclaimer, which provides that the patent that issues from the pending application must: 1) expire at the same time as the patent that is the basis of the double patenting rejection, and 2) cannot be assigned separately from the patent that is the basis of the double patenting rejection.  

    Upon filing a terminal disclaimer, an applicant should keep in mind that the common expiration date is mandatory, regardless of whether PTA would have otherwise extended the patent term of the disclaimed patent.  Therefore, applicants who opt to file a terminal disclaimer to overcome an obviousness-type double patenting rejection should carefully weigh the corresponding damage to the enforceable term of the disclaimed patent.  As an alternative to filing a terminal disclaimer, the applicant may wish to fight the rejection with substantive arguments, if any exist, or the applicant may wish to simply cancel the rejected claims and pursue them in a continuation application, if desired, and prosecute the remaining claims to allowance.
  • Do Not Fight Restriction Requirements

    During prosecution, the patent office may determine that an applicant’s claims are directed to more than one invention.  In these instances, the patent office may issue a restriction requirement that requires the applicant to select only one of the inventions for examination.  The applicant may respond by either: 1) selecting a single invention for examination (i.e., retaining only those claims directed to the selected invention and withdrawing the remaining claims), or 2) traversing the restriction requirement (i.e., arguing that all of the claims are directed to a single invention).

    The advantage of the traversing-the-restriction requirement is that all claims will stay in a single application that could issue at the same time in a single patent.  The significant disadvantage, however, is that the patent office may allow certain claims and reject others.  If the applicant decides to let the allowed claims proceed to issuance and then pursue the rejected claims in a continuation application, the applicant would then be vulnerable to an obviousness-type double patenting rejection.  As discussed above, the applicant would then be faced with the decision of whether to file a terminal disclaimer that may cut off valuable patent term, or fight the terminal disclaimer.

    Rather than traversing the restriction requirement, the applicant should consider accepting the restriction.  The applicant could then elect for examination only the claims that are drawn to a single invention, and then file one or more divisional applications to pursue the non-elected claims.  An advantage of this approach is that the patent office is barred from subsequently issuing an obviousness-type double patenting rejection in the divisional applications based on the parent application.  As a result, the applicant could avoid the filing of a terminal disclaimer, thereby maximizing the term of any patents that issue from the divisional applications.


By adjusting prosecution strategies, including appealing rejections before the first RCE where appropriate and avoiding terminal disclaimers, additional PTA may accrue into years of extra patent term.  Also, when patent applicants review PTA decisions, they should pay particular attention to whether, in accordance with Novartis, the USPTO added any additional B-Type PTA that accrued after the Notice of Allowance was mailed.  When applicants discover that the patent office's PTA calculation is incorrect, they must quickly submit a request for recalculation prior to paying the issue fee.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Perkins Coie | Attorney Advertising

Written by:

Perkins Coie

Perkins Coie on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.